Integer (NYSE:ITGR) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Integer (NYSE:ITGR) from a buy rating to a hold rating in a research note released on Saturday morning.

ITGR has been the topic of several other reports. Wells Fargo & Company restated an “equal weight” rating and set a $80.00 target price (down from $132.00) on shares of Integer in a research report on Friday, October 24th. Raymond James Financial reissued an “outperform” rating and set a $95.00 price target (down previously from $143.00) on shares of Integer in a research note on Friday, October 24th. Truist Financial upped their price target on Integer from $86.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Citigroup lifted their price objective on Integer from $69.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Finally, KeyCorp decreased their target price on Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Four research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $98.38.

Integer Trading Up 3.9%

Shares of ITGR stock opened at $79.81 on Friday. The business’s fifty day moving average price is $71.94 and its 200 day moving average price is $95.24. The firm has a market capitalization of $2.80 billion, a PE ratio of 33.39, a P/E/G ratio of 0.71 and a beta of 0.78. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. Integer has a 1-year low of $62.00 and a 1-year high of $146.36.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping the consensus estimate of $1.68 by $0.11. Integer had a net margin of 4.75% and a return on equity of 12.84%. During the same quarter last year, the company posted $1.43 EPS. The firm’s revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, sell-side analysts forecast that Integer will post 6.01 EPS for the current fiscal year.

Integer announced that its Board of Directors has approved a share repurchase plan on Tuesday, November 4th that authorizes the company to buyback $200.00 million in outstanding shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 8.3% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.

Insider Buying and Selling

In other Integer news, VP Tommy P. Thomas sold 884 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $70.15, for a total value of $62,012.60. Following the transaction, the vice president directly owned 3,596 shares in the company, valued at approximately $252,259.40. This represents a 19.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Diron Smith purchased 1,116 shares of the firm’s stock in a transaction on Friday, November 7th. The shares were purchased at an average cost of $67.19 per share, for a total transaction of $74,984.04. Following the completion of the purchase, the executive vice president directly owned 7,698 shares in the company, valued at $517,228.62. The trade was a 16.96% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired 5,843 shares of company stock valued at $384,771 over the last three months. Insiders own 2.16% of the company’s stock.

Hedge Funds Weigh In On Integer

A number of institutional investors have recently modified their holdings of the company. GAMMA Investing LLC lifted its stake in shares of Integer by 166.2% during the fourth quarter. GAMMA Investing LLC now owns 1,134 shares of the medical equipment provider’s stock valued at $89,000 after buying an additional 708 shares during the period. Mirabella Financial Services LLP acquired a new position in Integer in the 3rd quarter valued at $274,000. Tudor Investment Corp ET AL raised its holdings in Integer by 50,787.5% in the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock valued at $28,606,000 after acquiring an additional 29,442,029 shares during the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Integer during the 3rd quarter worth $380,000. Finally, CANADA LIFE ASSURANCE Co boosted its holdings in shares of Integer by 1.7% during the third quarter. CANADA LIFE ASSURANCE Co now owns 29,629 shares of the medical equipment provider’s stock worth $2,996,000 after purchasing an additional 502 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Multiple national plaintiff firms have announced class-action lawsuits alleging securities fraud against Integer covering July 25, 2024–Oct 22, 2025; these suits seek damages and could lead to costly litigation and distraction for management. CLASS ACTION NOTICE: Berger Montague Advises Integer Holdings Corporation (ITGR) Investors to Inquire About a Securities Fraud Class Action
• Negative Sentiment: Several firms (DJS Law Group, Schall Law Firm, Bernstein Liebhard, Gross Law Firm, Bronstein Gewirtz & Grossman, etc.) are soliciting investors to contact them about lead-plaintiff appointments and upcoming deadlines (many citing a Feb. 9, 2026 deadline for lead plaintiff filings). ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law Firm
• Negative Sentiment: Law firms are also publicizing an ongoing investigation (Portnoy Law Firm) and warning investors of losses tied to a prior sharp share decline — both raise the probability of consolidated litigation and settlement pressure. Integer Holdings Corporation Investigated by the Portnoy Law Firm
• Negative Sentiment: One firm (Bleichmar Fonti & Auld) links the litigation to a “significant stock drop,” signaling that plaintiffs will point to market declines as damages — this narrative can prolong volatility and deter some investors. ITGR DEADLINE UPCOMING: Integer Holdings Corporation Shareholders Are Notified to Contact BFA Law Before the February 9 Deadline

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.